Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Tumori|February 12, 2004
Biology and clinical application of the NIS geneRossella Elisei, Agnese Vivaldi, Furio Pacini
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2008
Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspectiveMarkus Luster, Martin Schlumberger, Furio Pacini
Thyroid : Official Journal of the American Thyroid Association|December 1, 2007
Clinical features and therapeutic implication of papillary thyroid microcarcinomaKalliopi Pazaitou-Panayiotou, Marco Capezzone, Furio Pacini
Current Genomics|June 2, 2010
Telomeres and thyroid cancerMarco Capezzone, Stefania Marchisotta, Silvia Cantara, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2011
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancerFurio Pacini, Mona M Sabra, R Michael Tuttle
Nature Reviews. Endocrinology|March 31, 2011
Telomerase and the endocrine systemFurio Pacini, Silvia Cantara, Marco Capezzone, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2016
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?Sophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
Nature Clinical Practice. Endocrinology & Metabolism|August 22, 2007
How the availability of recombinant human TSH has changed the management of patients who have thyroid cancerMartin Schlumberger, Marcel Ricard, Gérard De Pouvourville, et al.
The Lancet. Diabetes & Endocrinology|November 26, 2016
Papillary thyroid microcarcinoma and active surveillance - Authors' replySophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
The Lancet. Diabetes & Endocrinology|November 27, 2015
Management of advanced medullary thyroid cancerJulien Hadoux, Furio Pacini, R Michael Tuttle, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Tumori|February 12, 2004
Biology and clinical application of the NIS geneRossella Elisei, Agnese Vivaldi, Furio Pacini
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2008
Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspectiveMarkus Luster, Martin Schlumberger, Furio Pacini
Thyroid : Official Journal of the American Thyroid Association|December 1, 2007
Clinical features and therapeutic implication of papillary thyroid microcarcinomaKalliopi Pazaitou-Panayiotou, Marco Capezzone, Furio Pacini
Current Genomics|June 2, 2010
Telomeres and thyroid cancerMarco Capezzone, Stefania Marchisotta, Silvia Cantara, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2011
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancerFurio Pacini, Mona M Sabra, R Michael Tuttle
Nature Reviews. Endocrinology|March 31, 2011
Telomerase and the endocrine systemFurio Pacini, Silvia Cantara, Marco Capezzone, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2016
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?Sophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
Nature Clinical Practice. Endocrinology & Metabolism|August 22, 2007
How the availability of recombinant human TSH has changed the management of patients who have thyroid cancerMartin Schlumberger, Marcel Ricard, Gérard De Pouvourville, et al.
The Lancet. Diabetes & Endocrinology|November 26, 2016
Papillary thyroid microcarcinoma and active surveillance - Authors' replySophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
The Lancet. Diabetes & Endocrinology|November 27, 2015
Management of advanced medullary thyroid cancerJulien Hadoux, Furio Pacini, R Michael Tuttle, et al.
Pageof 15